Medigus Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 91.86 million compared to USD 10.12 million a year ago. Net loss was USD 9.82 million compared to net income of USD 6.79 million a year ago.

Basic loss per share from continuing operations was USD 6 compared to basic earnings per share from continuing operations of USD 3 a year ago. Diluted loss per share from continuing operations was USD 6 compared to diluted earnings per share from continuing operations of USD 3 a year ago.